DrugDashboards

Market view

secukinumab · Injection, Solution, Concentrate

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 150 mg/mL · Injection · #1 mL/carton · 150 mg/mL · Injection · #2 mL/carton · 300 mg/2mL · Injection · #1 syringe, glass/carton / 2 ml in 1 syringe, glass

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for secukinumab, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • CosentyxAug 19, 2026
    Price up
    NADAC $4082.85633 → $4088.10141 per unit (+0.13%)
  • CosentyxAug 19, 2026
    Price down
    NADAC $3936.20917 → $3924.35313 per unit (-0.3%)
  • CosentyxAug 19, 2026
    Price down
    NADAC $7875.874 → $7869.6275 per unit (-0.08%)
  • CosentyxAug 19, 2026
    Price up
    NADAC $7850.5425 → $7854.319 per unit (+0.05%)
  • CosentyxAug 19, 2026
    Price up
    NADAC $3938.84083 → $3941.79952 per unit (+0.08%)
  • CosentyxJul 22, 2026
    Price down
    NADAC $7869.832 → $7850.5425 per unit (-0.25%)
  • CosentyxJul 22, 2026
    Price down
    NADAC $3965.64399 → $3936.20917 per unit (-0.74%)
  • CosentyxJul 22, 2026
    Price down
    NADAC $4085.71976 → $4082.85633 per unit (-0.07%)
  • CosentyxJul 22, 2026
    Price down
    NADAC $7923.31344 → $7875.874 per unit (-0.6%)
  • CosentyxJul 22, 2026
    Price down
    NADAC $3961.2495 → $3938.84083 per unit (-0.57%)

Same drug class

Other molecules FDA puts in Interleukin-17A Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Secukinumab in shortage right now?
No. FDA does not currently list Secukinumab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Secukinumab?
2 companies have marketed Secukinumab in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Secukinumab cost?
The typical pharmacy pays about $4,088.10 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.